At the Centeno-Schultz Clinic we acknowledge the regenerative potential of stem cell therapy for common orthopedic conditions. Stem cell treatment utilizing Regenexx C and Regenexx SD has been used successfully as an alternative to
knee surgery and joint replacement
Peer reviewed studies have demonstrated its safety.
Regenexx utilizes a patient’s own stem cells which are referred to as autologous.
Stem cells can also come from donors and are referred to as allogeneic.
Is there a difference?
Yes as discussed in Dr. Centeno’s recent chapter on Stem Cell Therapy.
Autologous stem cell cells do not have the same communicable disease transmission risk as donor cells since they are the patient’s own cells.
Donor stem cells have the following concerns.
Gene transmission: Stem cells transplanted from the bone marrow of mice bred to have osteoporosis were able to induce osteoporosis in healthy mice.
Immunosuppressive potential is reduced in mismatched settings.